The Asia-to-US IPO corridor just posted its thinnest half-year. That is not the story.

The half-year numbers for Asian companies listing in the United States are in, and they are ugly enough to make a headline write itself. One IPO. About twelve million dollars raised. A year ago the same window carried thirty-nine deals and close to 886 million dollars. Read as a collapse, it looks like a door slamming. Read as arithmetic, it is a corridor doing exactly what it was rebuilt to do.

Let me put the figure down first, because it is the number every founder in the region will hear this month. Across the first half of 2026, companies whose business principally sits in China, a definition that reaches Hong Kong and Macau, completed exactly one initial public offering on a US exchange, raising in the order of twelve million dollars. In the first half of 2025 the same trade produced thirty-nine listings and something close to 886 million dollars. That is not a slowdown. On the surface it is an evaporation.

The instinct is to read that as the market rendering a verdict, namely that the United States has decided it no longer wants Asian companies and Asian companies have decided they no longer want the United States. That reading is wrong, or at least it is measuring the wrong thing. The number did not collapse because demand disappeared. It collapsed because the plumbing changed underneath it, and a lot of what used to flow through was never the kind of listing that should have been counted as a win in the first place.

What actually drove the number down

Two things, mostly. The first is a rule we have written about before. From the middle of June, Nasdaq Rule 5210(l) sets a 25 million dollar floor on the gross proceeds a China-based company must raise in a firm-commitment IPO, with parallel thresholds on business combinations and exchange transfers and a near-total ban on cheap direct listings. A large share of the thirty-nine deals from a year earlier were small, thin-float offerings that would simply not clear that bar. Remove them from the count and most of the year-on-year drop is explained before you reach any question about sentiment.

The second is timing. A rule that becomes operative in mid-June lands in the middle of a listing calendar, not at the start of one. Issuers who might have come in the second and third quarters are not walking away, they are pausing to work out which side of the new line they fall on and, where they fall short, how to restructure toward it. A freeze while people re-plan looks identical, in a half-year tally, to a market that has closed. It is not the same thing. Deloitte, reading the same tea leaves, expects the US window for Chinese issuers to stay slim and slow through the back half of the year, which is what a reset looks like while it is still resetting.

One deal in six months is not a market saying no. It is a filter that only just switched on, catching the tail it was built to catch.

So the honest description of the half-year is not “the corridor closed.” It is “the corridor lost its bottom end almost overnight, and its middle is holding its breath.” Those are very different diagnoses, and they point to very different decisions for the founder reading them.

The capital moved, but read where it moved to

The other half of the story is that the money did not leave the table, it changed seats. Hong Kong had a genuinely strong first half: IPO numbers up around 86 percent and proceeds up roughly 90 percent year on year, enough to put the city back among the top venues globally and behind only a Nasdaq lifted by a single enormous SpaceX listing. On 10 July, Shein cleared the China Securities Regulatory Commission to proceed with a Hong Kong listing of up to 341.6 million shares, after years of trying and failing to find a home in London and New York. If you want a symbol of the reroute, that is it.

But a symbol is not a template, and this is where regional founders need to be careful. Look at what actually carried Hong Kong's half-year. A handful of mega deals and a dozen large ones took up more than sixty percent of the proceeds, and the names driving them were China-tech, AI-value-chain, and A-share companies moving to a second listing at real scale. Hong Kong in 2026 is an outstanding venue if you are a large, China-anchored growth company. It is a much thinner promise if you are a forty-million-dollar Southeast Asian business that assumed the exit was interchangeable with Nasdaq. The reroute is real, but it is selective, and it selects for exactly the scale and story that a sub-scale issuer does not yet have.

The line most founders read on the wrong side

Here is the part that matters for the companies we actually work with. The 25 million dollar floor and its broad “China-based” definition do two things a Malaysian, Singaporean, or genuinely Southeast-Asian-anchored founder should understand precisely. They price the thin, sub-scale listing out of the US market, which is a headwind only if that was ever your plan. And they draw a geography line that you may be on the right side of without realising it.

A company whose assets, revenue, board, and control genuinely sit in Southeast Asia is not, on the face of it, a China-based issuer, even though the manipulation tail that used to taint the whole “Asian small-cap” comparison set is being legislated out around it. That is a quiet tailwind. But a regional company that quietly keeps the majority of its assets, revenue, or directors in Hong Kong or the mainland can be pulled under the China-based standard regardless of where its holding company is incorporated. Which side of that line you sit on is not a branding decision. It is a factual one, and it is knowable early, long before a prospectus is drafted.

The founder’s question stopped being “US or not.” It became “which side of the line am I on, and is Hong Kong my reroute or my consolation.”

What this means for us

We run the Kuala Lumpur, Hong Kong, Singapore corridor into Nasdaq and NYSE, and a half-year that reads as a collapse to the market reads to us as a clearing. The thirty-eight deals that are gone from the count were, overwhelmingly, the offerings we would never have underwritten to the bell in the first place: too small, too thin, too likely to drift toward a delisting notice inside eighteen months. What is left is the front door, a properly underwritten firm-commitment IPO with enough proceeds and float to trade, and the competition for underwriter and institutional attention in that lane just thinned dramatically.

So the counsel we are giving founders this month is not “the US is closed, pivot to Hong Kong.” It is more disciplined than that. Map honestly where your company legally lives, because that decides which rulebook you are graded against. Be candid about scale, because a Hong Kong reroute rewards size and a US listing now requires a real raise. And treat this half-year not as a verdict but as a sorting, because that is what it is. Being well sorted, on the right side of a line the exchange itself has drawn, is worth far more than being early through a door that was always going to be bricked up. The number is thin because the field is thinning. That is good news for the companies that were always meant to be in it.